Trinity Biotech (TRIB) Short Interest Ratio & Short Volume $0.55 +0.01 (+1.85%) Closing price 04/17/2025 03:58 PM EasternExtended Trading$0.55 +0.00 (+0.18%) As of 04/17/2025 05:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Trinity Biotech Short Interest DataTrinity Biotech (TRIB) has a short interest of 131,000 shares, representing 1.20% of the float (the number of shares available for trading by the public). This marks a -10.46% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 921,867 shares to cover all short positions.Current Short Interest131,000 sharesPrevious Short Interest146,300 sharesChange Vs. Previous Month-10.46%Dollar Volume Sold Short$74,670.00Short Interest Ratio0.1 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares18,054,000 sharesFloat Size10,960,000 sharesShort Percent of Float1.20%Today's Trading Volume32,619 sharesAverage Trading Volume921,867 sharesToday's Volume Vs. Average4% Short Selling Trinity Biotech? Sign up to receive the latest short interest report for Trinity Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTRIB Short Interest Over TimeTRIB Days to Cover Over TimeTRIB Percentage of Float Shorted Over Time Trinity Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2025131,000 shares $74,670.00 -10.5%1.2%0.1 $0.57 3/15/2025146,300 shares $100,230.13 -8.2%1.3%0.1 $0.69 2/28/2025159,300 shares $116,448.30 -59.9%1.5%0.1 $0.73 2/15/2025396,900 shares $301,644.00 -33.5%3.6%0.2 $0.76 1/31/2025596,800 shares $537,120.00 +921.9%5.3%0.3 $0.90 1/15/202558,400 shares $46,603.20 +100.7%0.5%0.3 $0.80 12/31/202429,100 shares $25,613.82 -50.3%0.3%0.1 $0.88 12/15/202458,500 shares $52,942.50 -17.1%0.5%0.3 $0.91 11/30/202470,600 shares $77,660.00 -8.2%0.6%0.4 $1.10 11/15/202476,900 shares $105,353.00 -18.3%0.7%0.1 $1.37 Get the Latest News and Ratings for TRIB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter. 10/31/202494,100 shares $165,616.00 -23.1%0.9%0.1 $1.76 10/15/2024122,300 shares $205,720.83 +22.3%1.1%0.1 $1.68 9/30/2024100,000 shares $110,000.00 +11.5%0.9%0.1 $1.10 9/15/202489,700 shares $143,520.00 -57.9%0.8%0.1 $1.60 8/31/2024213,200 shares $424,268.00 +1,232.5%1.8%0.2 $1.99 8/15/202416,000 shares $36,800.00 -25.6%0.2%0.3 $2.30 7/31/202421,500 shares $64,070.00 +16.9%0.3%0.4 $2.98 7/15/202418,400 shares $56,304.00 +70.4%0.3%0.4 $3.06 6/30/202410,800 shares $23,004.00 -71.5%0.2%0.2 $2.13 6/15/202437,900 shares $105,362.00 +213.2%0.5%0.9 $2.78 5/31/202412,100 shares $20,328.00 +63.5%0.2%0.5 $1.68 5/15/20247,400 shares $11,248.00 +516.7%0.1%0.4 $1.52 4/30/20241,200 shares $2,184.00 -36.8%0.0%0.1 $1.82 4/15/20241,900 shares $3,629.00 +58.3%0.0%0 $1.91 3/31/20241,200 shares $2,448.00 -72.1%0.0%0 $2.04 3/15/20244,300 shares $9,718.00 -71.9%0.1%0 $2.26 2/29/202415,300 shares $33,354.00 -5.0%0.2%0.2 $2.18 2/15/202416,100 shares $41,135.50 -46.9%N/A0.2 $2.56 1/31/202430,300 shares $17,877.00 +3.1%N/A0.1 $0.59 1/15/202429,400 shares $14,112.00 +92.2%N/A0.6 $0.48 12/31/202315,300 shares $6,563.70 -72.6%N/A0.3 $0.43 12/15/202355,800 shares $27,844.20 -14.6%N/A1.2 $0.50 11/30/202365,300 shares $31,148.10 +9.4%N/A1.8 $0.48 11/15/202359,700 shares $25,611.30 +70.1%N/A2.2 $0.43 10/31/202335,100 shares $16,146.00 +9.4%N/A1.3 $0.46 10/15/202332,100 shares $16,820.40 +23.0%N/A0.8 $0.52 9/30/202326,100 shares $19,186.11 +6.1%N/A0.6 $0.74 9/15/202324,600 shares $17,736.60 -1.6%N/A0.4 $0.72 8/31/202325,000 shares $20,000.00 +20.2%N/A0.4 $0.80 8/15/202320,800 shares $14,913.60 -59.9%N/A0.3 $0.72Trump’s treachery (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 7/31/202351,800 shares $49,210.00 +3.2%N/A0.8 $0.95 7/15/202350,200 shares $42,670.00 +27.4%N/A0.8 $0.85 6/30/202339,400 shares $37,473.34 -8.4%N/A0.8 $0.95 6/15/202343,000 shares $44,720.00 +91.1%N/A1 $1.04 5/31/202322,500 shares $20,925.00 -23.5%N/A0.5 $0.93 5/15/202329,400 shares $27,606.60 -18.3%N/A0.8 $0.94 4/30/202336,000 shares $37,972.80 -6.7%N/A1.1 $1.05 4/15/202338,600 shares $32,427.86 +33.1%N/A1.3 $0.84 3/31/202329,000 shares $27,260.00 -23.1%N/A1.2 $0.94 3/15/202337,700 shares $36,188.23 +10.9%N/A1.5 $0.96 2/28/202334,000 shares $35,870.00 -11.9%N/A1.3 $1.06 2/15/202338,600 shares $41,109.00 -1.5%N/A1.5 $1.07 1/31/202339,200 shares $42,140.00 -35.3%N/A1.3 $1.08 1/15/202360,600 shares $64,236.00 -19.8%N/A1.8 $1.06 12/30/202275,600 shares $74,844.00 -5.4%N/A2.3 $0.99 12/15/202279,900 shares $92,684.00 -23.8%N/A2.4 $1.16 11/30/2022104,900 shares $139,517.00 -22.0%N/A3.2 $1.33 11/15/2022134,400 shares $178,752.00 -2.9%N/A3.7 $1.33 10/31/2022138,400 shares $160,544.00 -17.1%N/A4.2 $1.16 10/15/2022166,900 shares $198,627.69 -12.7%N/A4.7 $1.19 9/30/2022191,200 shares $204,775.20 -12.1%N/A5.2 $1.07 9/15/2022217,400 shares $256,532.00 -13.9%N/A5.3 $1.18 8/31/2022252,500 shares $308,050.00 -13.4%N/A5.8 $1.22 8/15/2022291,700 shares $402,546.00 -19.6%N/A6.1 $1.38 7/31/2022362,800 shares $493,408.00 -19.8%N/A5.9 $1.36 7/15/2022452,600 shares $624,588.00 +1.0%N/A4.7 $1.38 6/30/2022448,100 shares $551,163.00 -6.4%N/A0.7 $1.23 6/15/2022478,700 shares $588,801.00 +2.9%N/A0.7 $1.23 5/31/2022465,100 shares $660,442.00 +10.6%N/A0.7 $1.42 5/15/2022420,600 shares $492,102.00 +1.8%N/A0.6 $1.17 4/30/2022413,100 shares $491,589.00 -34.1%N/A0.6 $1.19 4/15/2022626,900 shares $764,818.00 +246.0%N/A0.9 $1.22 3/31/2022181,200 shares $192,072.00 -23.2%N/A1.4 $1.06 3/15/2022235,800 shares $231,060.42 +6.5%N/A1.8 $0.98 2/28/2022221,400 shares $225,828.00 +32.1%N/A1.5 $1.02 2/15/2022167,600 shares $191,064.00 -20.2%N/A1.2 $1.14 1/31/2022210,100 shares $241,615.00 -73.4%N/A1.8 $1.15 1/15/2022790,500 shares $1.09 million +36.5%N/A7.2 $1.39 12/31/2021579,200 shares $828,256.00 +103.8%N/A5.4 $1.43 12/15/2021284,200 shares $477,456.00 -7.3%N/A2.6 $1.68 11/30/2021306,400 shares $566,840.00 +4.2%N/A2.8 $1.85 11/15/2021294,000 shares $585,060.00 -9.4%N/A2.6 $1.99 10/29/2021324,600 shares $668,676.00 +10.5%N/A2.5 $2.06 10/15/2021293,900 shares $596,617.00 +5.2%N/A1.8 $2.03 9/30/2021279,300 shares $603,288.00 +0.0%N/A1.3 $2.16 9/15/2021279,200 shares $664,496.00 -14.9%N/A1.4 $2.38 8/31/2021327,900 shares $855,819.00 +23.4%N/A1.6 $2.61 8/13/2021265,700 shares $581,883.00 -0.2%N/A1.4 $2.19 7/30/2021266,300 shares $583,197.00 +4.6%1.3%1 $2.19 7/15/2021254,500 shares $521,725.00 -10.1%1.2%1 $2.05Trump’s treachery (Ad)Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma 6/30/2021283,200 shares $832,608.00 -1.9%1.4%1.3 $2.94 6/15/2021288,800 shares $901,056.00 -13.7%1.4%1 $3.12 5/28/2021334,700 shares $1.05 million +19.7%1.6%1.1 $3.13 5/14/2021279,600 shares $939,456.00 -18.0%1.4%0.8 $3.36 4/30/2021340,900 shares $1.17 million -17.7%1.7%1.1 $3.43 4/15/2021414,200 shares $1.61 million +13.5%2.0%0.8 $3.88 3/31/2021364,900 shares $1.44 million -3.0%1.8%0.7 $3.95 3/15/2021376,300 shares $1.73 million +45.8%1.8%0.8 $4.61 2/26/2021258,100 shares $1.36 million +59.1%N/A0.6 $5.28 2/12/2021162,200 shares $981,310.00 +22.0%0.8%0.3 $6.05 1/29/2021133,000 shares $573,230.00 +4.7%N/A0.3 $4.31 1/15/2021127,000 shares $514,350.00 -15.3%N/A0.4 $4.05 12/31/2020150,000 shares $582,000.00 +32.4%N/A0.5 $3.88 12/15/2020113,300 shares $491,722.00 +0.7%N/A0.4 $4.34 11/30/2020112,500 shares $497,250.00 +72.0%N/A0.3 $4.42 11/15/202065,400 shares $197,508.00 +15.8%N/A0.2 $3.02 10/30/202056,500 shares $155,940.00 +52.7%N/A0.1 $2.76 10/15/202037,000 shares $96,570.00 +56.8%N/A0.1 $2.61 9/30/202023,600 shares $47,672.00 -62.1%N/A0 $2.02 9/15/202062,300 shares $141,421.00 -54.4%N/A0.1 $2.27 8/31/2020136,700 shares $263,831.00 -75.6%N/A0.2 $1.93 8/14/2020560,200 shares $1.28 million -0.7%N/A0.5 $2.28 7/31/2020564,400 shares $1.41 million -12.6%N/A0.6 $2.49 7/15/2020646,000 shares $1.64 million -2.2%N/A0.7 $2.54 6/30/2020660,700 shares $1.44 million -5.6%N/A0.7 $2.18 6/15/2020699,700 shares $1.36 million +14.4%N/A0.7 $1.95 5/29/2020611,500 shares $776,605.00 -3.0%N/A0.7 $1.27 5/15/2020630,300 shares $945,450.00 +25.4%N/A0.6 $1.50 4/30/2020502,800 shares $799,452.00 +130.4%N/A0.6 $1.59 TRIB Short Interest - Frequently Asked Questions What is Trinity Biotech's current short interest? Short interest is the volume of Trinity Biotech shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 131,000 shares of TRIB short. 1.20% of Trinity Biotech's shares are currently sold short. Learn More on Trinity Biotech's current short interest. Which institutional investors are shorting Trinity Biotech? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Trinity Biotech: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Trinity Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.20% of Trinity Biotech's floating shares are currently sold short. Is Trinity Biotech's short interest increasing or decreasing? Trinity Biotech saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 131,000 shares, a drop of 10.5% from the previous total of 146,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Trinity Biotech's float size? Trinity Biotech currently has issued a total of 18,054,000 shares. Some of Trinity Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Trinity Biotech currently has a public float of 10,960,000 shares. How does Trinity Biotech's short interest compare to its competitors? 1.20% of Trinity Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Trinity Biotech: Skye Bioscience, Inc. (12.71%), Mersana Therapeutics, Inc. (8.88%), Aadi Bioscience, Inc. (6.58%), Celularity Inc. (12.08%), Repare Therapeutics Inc. (2.61%), Spero Therapeutics, Inc. (0.96%), Iterum Therapeutics plc (4.43%), Anebulo Pharmaceuticals, Inc. (0.11%), SCYNEXIS, Inc. (2.03%), Prelude Therapeutics Incorporated (6.92%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Trinity Biotech stock? Short selling TRIB is an investing strategy that aims to generate trading profit from Trinity Biotech as its price is falling. TRIB shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Trinity Biotech? A short squeeze for Trinity Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TRIB, which in turn drives the price of the stock up even further. How often is Trinity Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TRIB, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies Skye Bioscience Short Interest Data Mersana Therapeutics Short Interest Data Aadi Bioscience Short Interest Data Celularity Short Interest Data Repare Therapeutics Short Interest Data Spero Therapeutics Short Interest Data Iterum Therapeutics Short Interest Data Anebulo Pharmaceuticals Short Interest Data SCYNEXIS Short Interest Data Prelude Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TRIB) was last updated on 4/21/2025 by MarketBeat.com Staff From Our PartnersGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredAmazon ShockerJeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trinity Biotech plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Trinity Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
